Try our Advanced Search for more refined results
Product Liability
-
March 05, 2026
Mom Hit By Tesla-Driving Toddler Can't Undo Trial Loss
A California state appellate panel affirmed a midtrial win for Tesla in a suit brought by a mother who was struck by a Tesla driven by her toddler, saying she used the wrong legal standard to characterize her claim that certain features were defectively designed.
-
March 05, 2026
Hyundai Faces $9.8M Sanction For Car Destruction
A Pennsylvania court has awarded two car dealerships nearly $9.8 million as a sanction against Hyundai Motor America after finding Hyundai "consciously" crushed cars they acquired before alleging, without evidence, that they intentionally damaged them to exploit Hyundai's vehicle repurchases.
-
March 05, 2026
TRESemmé Hair Loss Suit Tossed By Judge
A New Jersey federal judge on Wednesday tossed with prejudice a suit alleging that TRESemmé shampoo causes hair loss after the plaintiff's sole expert was barred from testifying as he admitted his opinion was wrong.
-
March 05, 2026
GM Sued Over 'Catastrophic' Failures That Can Cause Fires
Newer-model Buick and Chevrolet vehicles equipped with a 1.2-liter turbocharged engine can suffer "catastrophic internal failures," causing loss of power and even fires, according to a proposed class action filed in Delaware federal court accusing General Motors LLC of concealing the problem.
-
March 05, 2026
Gold Mine Poses No Certain Threat To Belugas, Gov't Argues
The federal government wants to end litigation by environmental groups seeking to stop a mining company from expanding gold extraction efforts within an Alaska national park, telling a federal court that any alleged harm to the endangered beluga whales living in a nearby bay is speculative.
-
March 05, 2026
4th Circ. Allows Insurer To Seek Arbitration In Foam Case
The Fourth Circuit on Wednesday overturned an order barring Illinois Union Insurance Co. from seeking to arbitrate in London a dispute within multidistrict litigation over alleged contamination from firefighting foam for failing to obtain consent from co-lead counsel.
-
March 05, 2026
Neb. AG Hits Roblox With Suit Over Kid Safety
Nebraska on Wednesday became the latest state to hit popular gaming platform Roblox with a suit alleging that it fails to protect children against online predators, saying even new age verification policies are not enough to safeguard minors.
-
March 04, 2026
Amazon Shoppers' Attys Must Explain AI Use In Botched Brief
A Washington federal judge Wednesday ordered attorneys representing Amazon customers in a proposed class action alleging deceptive supplement labeling to explain whether and how generative artificial intelligence was used in a filing with errors they've since apologized for, and what "verification mechanisms" they had for the nascent technology's use.
-
March 04, 2026
Zuckerberg Denies 'Addiction' In Testimony Played To NM Jury
New Mexico jurors saw videotaped testimony Wednesday from Mark Zuckerberg in the state attorney general's social media mental health trial in which the Meta CEO acknowledged that "problematic use" is a well-known problem among accountholders but rejected labels like "addiction" and "habit-forming."
-
March 04, 2026
Meta Seeks Bench Trial, Not Jury, In Mental Health MDL
Facebook and Instagram's parent company has had a change of heart when it comes to facing a jury on claims they caused underage users to become addicted to their platforms, resulting in emotional harm, telling the California federal judge overseeing the multidistrict litigation that they would now prefer a bench trial.
-
March 04, 2026
Social Media Addiction Fed Girl's Conflict With Mom, Jury Told
A UCLA psychiatrist testified Wednesday in a landmark bellwether trial over allegations that using Instagram and YouTube harm children's mental health, saying that a girl's social media addiction contributed to friction with her mother.
-
March 04, 2026
$7.25B Nationwide Roundup Deal Gets First Approval
A Missouri state court on Wednesday gave a preliminary nod of approval to a settlement that could pay up to $7.25 billion over 21 years to resolve current and future claims across the U.S. that weed killer Roundup causes non-Hodgkin lymphoma, two weeks after the deal was announced.
-
March 04, 2026
Regeneron, Sanofi Didn't Warn About Cancer Risk, Suit Says
Regeneron Pharmaceuticals and Sanofi-Aventis were sued Tuesday in Georgia federal court by a woman who said she experienced rapid progression of cutaneous T-cell lymphoma after getting injections of dupilumab, a medication the companies sell as Dupixent as a treatment for inflammation.
-
March 04, 2026
Justices Mull Cracks In Freight Broker Liability Shield
The U.S. Supreme Court appeared unsure Wednesday whether a federal law economically deregulating the commercial trucking industry also extends to shielding freight brokers from state-law liability for highway crashes that have killed or injured people.
-
March 04, 2026
Zantac Investor Class Action Time-Barred, Pa. Judge Rules
The maker of heartburn and acid reflux relief tablet Zantac has defeated a securities fraud class action claiming the company hid for decades the cancer risks associated with the drug, causing a stock price drop when the truth was revealed, after a Pennsylvania federal judge ruled Wednesday that the claims were untimely.
-
March 04, 2026
9th Circ. Hesitant To Revive Implant Suit Against Medtronic
A Ninth Circuit panel cast doubt Wednesday on a Washington man's attempt to revive a negligence lawsuit against Medtronic for allegedly not assisting him when his spinal implant malfunctioned, hinting that his failure to find an expert witness to testify the device caused his pain may be fatal to the case.
-
March 04, 2026
Supreme Court Rejects NJ Immunity Defense In NY, Pa. Suits
The U.S. Supreme Court ruled Wednesday that New Jersey cannot shield its public transit system from personal injury lawsuits by out-of-state plaintiffs under the doctrine of sovereign immunity.
-
March 03, 2026
EPA Fights Fluoridated Water IQ Risk Finding At 9th Circ.
The U.S. Environmental Protection Agency urged the Ninth Circuit on Tuesday to reverse a ruling that the EPA's current "optimal" level of fluoride in drinking water poses an unreasonable risk of lowering children's IQ, arguing that the trial judge improperly held his ruling in abeyance for years to await more scientific evidence.
-
March 03, 2026
Meta Atty's Slip Reveals Social Media Trial Plaintiff's Identity
An attorney for Meta Platforms on Tuesday revealed the highly guarded full name of the plaintiff in a landmark bellwether trial accusing its Instagram platform and Google's YouTube of harming children's mental health, prompting the Los Angeles judge overseeing the case to strike it from the record and order everyone in the courtroom not to reveal it.
-
March 03, 2026
Calif. Sued Over Cancer Warning Law For Personal Care
Forcing makeup and personal care companies to place Proposition 65 warning labels on products containing the chemical diethanolamine, or DEA, violates the First Amendment, according to a California federal lawsuit, which argues the practice is costing companies millions.
-
March 03, 2026
Feds, State AGs And Biz Groups Back Monsanto At High Court
The federal government, 15 state attorneys general and business groups, among others, urged the U.S. Supreme Court on Monday to strike down a $1.25 million verdict in a suit over claims Monsanto's Roundup weed killer causes cancer, saying that "patchwork" labeling regulations would harm the nation's farmers.
-
March 03, 2026
Terminix Wins Coverage For $8M Pesticide Exposure Award
An excess insurer must cover part of an $8 million judgment entered against Terminix in a pesticide exposure suit, the Ninth Circuit said Tuesday, affirming that the underlying injury arose out of Terminix's product for the purposes of the policy's "products-completed operations hazard" coverage.
-
March 03, 2026
Hawaiian Electric Investors Get First OK Of $48M Wildfire Deal
Hawaiian Electric Industries Inc. and its investors have received initial approval of their nearly $48 million deal settling a California federal suit blaming it for the downturn in its stock price following a deadly 2023 fire on Maui.
-
March 03, 2026
Conn. Beats Challenge To Open Carry Ban, Handgun Limits
Two gun owners and an Idaho-based nonprofit lack standing to sue a Connecticut prosecutor in an effort to invalidate the state's open carry ban and its three-per-month limitation on handgun purchases, a federal judge has ruled.
-
March 03, 2026
Sanofi Gets Approval For Interlocutory Appeal In Taxotere MDL
Pharmaceutical company Sanofi will get a chance to ask the Fifth Circuit to end multidistrict litigation claiming it failed to warn cancer patients about the risk of eye injuries caused by its chemotherapy drug Taxotere, arguing that a label ruling that allowed generic-drug makers out of the case should also apply to it.
Expert Analysis
-
4 Quick Emotional Resets For Lawyers With Conflict Fatigue
Though the emotional wear and tear of legal work can trap attorneys in conflict fatigue — leaving them unable to shake off tense interactions or return to a calm baseline — simple therapeutic techniques for resetting the nervous system can help break the cycle, says Chantel Cohen at CWC Coaching & Therapy.
-
Rescheduling Cannabis Marks New Tax Era For Operators
As the attorney general takes steps to move cannabis from Schedule I to Schedule III of the Controlled Substances Act, operators and advisers should prepare by considering the significant changes this will bring from tax, state, industry and market perspectives, says Michael Harlow at CohnReznick.
-
Series
Playing Tennis Makes Me A Better Lawyer
An instinct to turn pain into purpose meant frequent trips to the tennis court, where learning to move ahead one point at a time was a lesson that also applied to the steep learning curve of patent prosecution law, says Daniel Henry at Marshall Gerstein.
-
False Ad Suit Shows Need For Clear, Conspicuous Disclosure
The Eleventh Circuit's recent false advertising decision in Federal Trade Commission v. Corpay reiterated the FTC's guidance imploring advertisers to ensure that any disclosures are clear and conspicuous to consumers, providing companies with numerous lessons about truthful advertising and highlighting some common disclosure pitfalls to avoid, says Michael Justus at Carlton Fields.
-
How Generative AI Cos. Can Navigate Product Liability Claims
Increasingly, plaintiffs are aggregating disputes over generative artificial intelligence and pursuing them through mass-tort-style proceedings, borrowing tactics from litigation involving social media, pharmaceuticals and other consumer-facing products — but there are approaches that AI companies can use to narrow claims and manage long-term exposure, say attorneys at Arnold & Porter.
-
And Now A Word From The Panel: MDL Year In Review
2025 was a roller coaster for the Judicial Panel on Multidistrict Litigation, with the panel canceling one hearing session due to the absence of new MDL petitions, yet also issuing rulings on more new MDL petitions than in 2024 — making it clear that MDLs are still thriving, says Alan Rothman at Sidley Austin.
-
Class Actions At The Circuit Courts: January Lessons
In this month's review of class action appeals, Mitchell Engel at Shook Hardy discusses five rulings from October and November, and identifies practice tips from cases involving consumer fraud, oil and gas leases, toxic torts, and wage and hour issues.
-
Series
Judges On AI: How Judicial Use Informs Guardrails
U.S. Magistrate Judge Maritza Dominguez Braswell at the U.S. District Court for the District of Colorado discusses why having a sense of how generative AI tools behave, where they add value, where they introduce risk and how they are reshaping the practice of law is key for today's judges.
-
What US Cos. Must Know To Comply With Italy's AI Law
Italy's newly effective artificial intelligence law means U.S. companies operating in Italy or serving Italian customers must now meet EU AI Act obligations as well as Italy-specific requirements, including immediately enforceable criminal penalties, designated national authorities and sector-specific mandates, say attorneys at Portolano Cavallo.
-
Navigating Battery Validation Risk In The EV Supply Chain
Vehicle electrification has moved battery system supply chains from a background component into the center of the automotive universe — and for legal teams, battery validation is now a driver of contractual disputes, regulatory exposure and even shareholder litigation, say Samuel Madden at Secretariat Advisors and Vanessa Miller at Foley & Lardner.
-
Series
Adapting To Private Practice: 5 Tips From Ex-SEC Unit Chief
My move to private practice has reaffirmed my belief in the value of adaptability, collaboration and strategic thinking — qualities that are essential not only for successful client outcomes, but also for sustained professional satisfaction, says Dabney O’Riordan at Fried Frank.
-
Series
Law School's Missed Lessons: How To Start A Law Firm
Launching and sustaining a law firm requires skills most law schools don't teach, but every lawyer should understand a few core principles that can make the leap calculated rather than reckless, says Sam Katz at Athlaw.
-
Key False Claims Act Trends From The Last Year
The False Claims Act remains a powerful enforcement tool after some record verdicts and settlements in 2025, and while traditional fraud areas remain a priority, new initiatives are raising questions about its expanding application, says Veronica Nannis at Joseph Greenwald.
-
Reel Justice: 'Die My Love' And The Power Of Visuals At Trial
The powerful use of imagery to capture the protagonist’s experience of postpartum depression in “Die My Love” reminds attorneys that visuals at trial can persuade jurors more than words alone, so they should strategically wield a new federal evidence rule allowing for illustrative aids, says Veronica Finkelstein at Wilmington University.
-
Opinion
It's Too Soon To Remove Suicide Warnings From GLP-1 Drugs
The U.S. Food and Drug Administration's decision this month to order removal of warnings about the risk of suicidal thoughts from GLP-1 weight-loss drugs is premature — and from a safety and legal standpoint, the downside of acting too soon could be profound, says Sean Domnick at Rafferty Domnick.